These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Biasucci LM; Biasillo G; Stefanelli A Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311 [TBL] [Abstract][Full Text] [Related]
7. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk. Robinson JG Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323 [TBL] [Abstract][Full Text] [Related]
8. Effect of statins on breast cancer recurrence and mortality: a review. Van Wyhe RD; Rahal OM; Woodward WA Breast Cancer (Dove Med Press); 2017; 9():559-565. PubMed ID: 29238220 [TBL] [Abstract][Full Text] [Related]
9. Effects of statin therapy on the progression of chronic kidney disease. Shah S; Paparello J; Danesh FR Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. Miida T; Hirayama S; Nakamura Y J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707 [TBL] [Abstract][Full Text] [Related]
11. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
12. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice. Bruckert E; Ferrières J Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429 [TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. Epstein M; Campese VM Am J Kidney Dis; 2005 Jan; 45(1):2-14. PubMed ID: 15696439 [TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Marzilli M Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728 [TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of statins and related pharmacological experimental approaches. Alegret M; Silvestre JS Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancer. Desai P; Jay A; Bock C; Dyson G; Okwuosa T; Simon MS Int J Mol Epidemiol Genet; 2013 Nov; 4(4):183-92. PubMed ID: 24319534 [TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of statins and related pharmacological experimental approaches. Alegret M; Silvestre JS Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729 [TBL] [Abstract][Full Text] [Related]
19. Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer. Piekuś-Słomka N; Mocan LP; Shkreli R; Grapă C; Denkiewicz K; Wesolowska O; Kornek M; Spârchez Z; Słomka A; Crăciun R; Mocan T Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894467 [TBL] [Abstract][Full Text] [Related]